Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease

W Dai, L Long, X Wang, S Li, H Xu - Chinese medicine, 2022 - Springer
Inflammatory bowel disease (IBD) is a collective term for inflammatory diseases including
Crohn's disease and ulcerative colitis. Toll-like receptor 4 (TLR4) is thought to play a key …

Jatrorrhizine: a review of sources, pharmacology, pharmacokinetics and toxicity

F Zhong, Y Chen, J Chen, H Liao, Y Li… - Frontiers in …, 2022 - frontiersin.org
Jatrorrhizine, an isoquinoline alkaloid, is a bioactive metabolite in common medicinal plants,
such as Berberis vernae Schneid., Tinospora sagittata (Oliv.) Gagnep. and Coptis chinensis …

Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: impact on intestinal epithelial barrier, gut microbiota …

C Li, G Ai, Y Wang, Q Lu, C Luo, L Tan, G Lin… - Pharmacological …, 2020 - Elsevier
Abstract Berberine (BBR), a naturally-occurring isoquinoline alkaloid isolated from several
Chinese herbal medicines, has been widely used for the treatment of dysentery and colitis …

Plant alkaloids: Structures and bioactive properties

EP Gutiérrez-Grijalva, LX López-Martínez… - Plant-derived bioactives …, 2020 - Springer
Alkaloids are nitrogen-containing natural products found in bacteria, fungi, animals, and
plants with complex and diverse structures. The widespread distribution of alkaloids along …

In vitro cytotoxic activity of methanol extracts of selected medicinal plants traditionally used in Mexico against human hepatocellular carcinoma

JH Elizondo-Luévano, R Gomez-Flores, MJ Verde-Star… - Plants, 2022 - mdpi.com
Medicinal plants are traditionally used in Mexico to treat diseases such as cancer. The
present study aimed to evaluate the cytotoxic, antioxidant, and anti-hemolytic activity of 15 …

Alkaloids and colon cancer: molecular mechanisms and therapeutic implications for cell cycle arrest

H Khan, W Alam, KF Alsharif, M Aschner, S Pervez… - Molecules, 2022 - mdpi.com
Cancer is the second most fatal disease worldwide, with colon cancer being the third most
prevalent and fatal form of cancer in several Western countries. The risk of acquisition of …

Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review

Y Cai, Q Yang, Y Yu, F Yang, R Bai… - Frontiers in pharmacology, 2023 - frontiersin.org
Lipid-lowering therapy is an important tool for the treatment of lipid metabolic diseases,
which are increasing in prevalence. However, the failure of conventional lipid-lowering …

Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats

QP Li, YX Dou, ZW Huang, HB Chen, YC Li, JN Chen… - Phytomedicine, 2021 - Elsevier
Background Berberine (BBR) has been widely used to treat non-alcoholic fatty liver disease
(NAFLD). The metabolites of BBR were believed to contribute significantly to its …

Berberine attenuates liver fibrosis by autophagy inhibition triggering apoptosis via the miR-30a-5p/ATG5 axis

Y Tan, C Li, J Zhou, F Deng, Y Liu - Experimental Cell Research, 2023 - Elsevier
Berberine (BBR) is an effective drug against liver fibrosis (LF). Autophagy is involved in the
pathogenesis of LF; however, the mechanism linking BBR to autophagy in LF remains …

Biogenic synthesis of gold nanoparticles using Argemone mexicana L. and their cytotoxic and genotoxic effects on human colon cancer cell line (HCT-15)

KD Datkhile, SR Patil, PP Durgawale, MN Patil… - Journal of Genetic …, 2021 - Springer
Background Nanomedicine has evolved as precision medicine in novel therapeutic
approach of cancer management. The present study investigated the efficacy of biogenic …